Clinical Trials Directory

Trials / Completed

CompletedNCT07534631

Holmium Laser En-Bloc Resection Versus Conventional Transurethral Resection of Bladder Tumors for Treatment of Non-muscle- Invasive Bladder Cancer

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
100 (actual)
Sponsor
Beni-Suef University · Academic / Other
Sex
All
Age
30 Years
Healthy volunteers
Not accepted

Summary

This study is a prospective randomized controlled trial comparing holmium laser en-bloc resection of bladder tumor (HoLERBT) with conventional transurethral resection of bladder tumor (cTURBT) in patients with suspected non-muscle-invasive bladder cancer (NMIBC). A total of 100 patients will be randomly assigned in a 1:1 ratio to undergo either HoLERBT or cTURBT. The primary outcome is the quality of the pathological specimen, assessed by the presence of detrusor muscle. Secondary outcomes include perioperative complications, operative time, obturator nerve reflex, bladder perforation, positive surgical margins, persistent disease at second-look TURBT, and recurrence rates at 3 and 12 months, as well as recurrence-free survival. This study aims to evaluate whether HoLERBT provides superior resection quality and improved clinical outcomes compared to conventional TURBT.

Conditions

Interventions

TypeNameDescription
PROCEDUREHolmium Laser En-Bloc Resection of Bladder TumorHolmium laser en-bloc resection of bladder tumor (HoLERBT) is a surgical technique in which the bladder tumor is removed in a single piece using a holmium laser. The procedure allows precise dissection, improved hemostasis, and better preservation of specimen integrity for pathological assessment.
PROCEDUREConventional Transurethral Resection of Bladder TumorConventional transurethral resection of bladder tumor (cTURBT) is a standard surgical procedure in which the tumor is removed in multiple fragments using a monopolar or bipolar resectoscope.

Timeline

Start date
2025-01-05
Primary completion
2025-10-05
Completion
2026-01-05
First posted
2026-04-16
Last updated
2026-04-16

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT07534631. Inclusion in this directory is not an endorsement.